Zhejiang Jolly Pharmaceutical Co Ltd (300181.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100001096

Price
12.35 CNY
Market cap
8.66 bn CNY
P/E (2025)
13.71
P/S (2025)
2.85
Dividend yield
5.67 %
Net margin
20.78 %
Return on equity (ROE)
19.87 %
Return on assets (ROA)
13.41 %

Zhejiang Jolly Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue2.58 bn CNY3.04 bn CNY
Gross profit1.56 bn CNY1.87 bn CNY
Operating income609.29 m CNY796.99 m CNY
EBIT590.51 m CNY770.11 m CNY
Net income507.77 m CNY631.93 m CNY
Diluted EPS – continuing operations0.73 CNY0.90 CNY

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Zhejiang Jolly Pharmaceutical Co Ltd

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. It invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.